1. Home
  2. PTGX vs LW Comparison

PTGX vs LW Comparison

Compare PTGX & LW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$95.98

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Logo Lamb Weston Holdings Inc.

LW

Lamb Weston Holdings Inc.

HOLD

Current Price

$41.93

Market Cap

5.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTGX
LW
Founded
2006
1950
Country
United States
United States
Employees
N/A
10100
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
5.9B
IPO Year
2016
2016

Fundamental Metrics

Financial Performance
Metric
PTGX
LW
Price
$95.98
$41.93
Analyst Decision
Strong Buy
Hold
Analyst Count
13
7
Target Price
$108.23
$44.14
AVG Volume (30 Days)
455.9K
1.5M
Earning Date
05-07-2026
04-01-2026
Dividend Yield
N/A
3.53%
EPS Growth
N/A
N/A
EPS
0.05
1.29
Revenue
N/A
N/A
Revenue This Year
$874.25
$4.26
Revenue Next Year
N/A
N/A
P/E Ratio
$1,898.40
$33.00
Revenue Growth
N/A
N/A
52 Week Low
$49.86
$37.62
52 Week High
$107.84
$67.07

Technical Indicators

Market Signals
Indicator
PTGX
LW
Relative Strength Index (RSI) 44.81 46.89
Support Level $96.36 $40.25
Resistance Level $100.00 $42.69
Average True Range (ATR) 3.91 1.46
MACD -0.55 0.00
Stochastic Oscillator 29.62 45.46

Price Performance

Historical Comparison
PTGX
LW

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

About LW Lamb Weston Holdings Inc.

Lamb Weston is North America's largest and the world's second-largest producer of branded and private-label frozen potato products, both by volume and value. The company's portfolio is anchored by french fries, but it also sells sweet potato fries, tater tots, diced potatoes, mashed potatoes, hash browns, and chips. Roughly two thirds of revenue comes from its home market of North America, with none of the other 100 countries the company sells into representing a significant share. McDonald's is Lamb Weston's single-largest customer at 15% of fiscal 2025 sales, with no other company representing more than 10%. Lamb Weston became an independent company in 2016 when it was spun off from Conagra.

Share on Social Networks: